Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics? By: Motley Fool January 22, 2023 at 09:00 AM EST Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies. Read More >> Related Stocks: Bluebird Bio Crispr Therapeutics Ag Vertex Pharmaceuticals